Literature DB >> 6580910

Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2 alpha.

M A Lumsden, R W Kelly, D T Baird.   

Abstract

Menstrual fluid was collected in a contraceptive diaphragm from 16 women with primary dysmenorrhoea and 12 matched control subjects without dysmenorrhoea. Prostaglandins F2 alpha (PGF2 alpha), E2 (PGE2) and 6-oxo-prostaglandin F1 alpha (6-oxo-PGF1 alpha) were extracted and measured using gas-chromatography: mass spectrometry (GC:MS). The concentrations of both PGF2 alpha and PGE2 were higher on days 1 and 2 in the dysmenorrhoea group than in the control group and the concentration of PGF2 alpha was higher on day 1 than on day 2 in the dysmenorrhoea group. The concentrations of 6-oxo-PGF1 alpha (the stable metabolite of PGI2) were low in both groups. These results confirm suggestions that PGF2 alpha is important in the aetiology of dysmenorrhoea and also indicate that PGE2 may be involved.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6580910     DOI: 10.1111/j.1471-0528.1983.tb06460.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  18 in total

1.  F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.

Authors:  K J Sales; S C Boddy; H N Jabbour
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

Review 2.  Inflammation, leukocytes and menstruation.

Authors:  Jemma Evans; Lois A Salamonsen
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

3.  A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.

Authors:  Kurt J Sales; Tammy List; Sheila C Boddy; Alistair R W Williams; Richard A Anderson; Zvi Naor; Henry N Jabbour
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

4.  Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation.

Authors:  O P Milling Smith; H N Jabbour; H O D Critchley
Journal:  Hum Reprod       Date:  2007-01-30       Impact factor: 6.918

5.  Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway.

Authors:  S Battersby; K J Sales; A R Williams; R A Anderson; S Gardner; H N Jabbour
Journal:  Hum Reprod       Date:  2006-08-12       Impact factor: 6.918

6.  Animal study on primary dysmenorrhoea treatment at different administration times.

Authors:  Bao-Chan Pu; Ling Fang; Li-Na Gao; Rui Liu; Ai-Zhu Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-02       Impact factor: 2.629

7.  Potential mechanisms of an antiadenomyosis chinese herbal formula shaoyao-gancao decoction in primary cell culture model.

Authors:  Yong-Ge Guan; Jin-Bin Liao; Kun-Yin Li; Yu-Cui Li; Yang Song; Jing Ling; Zi-Ren Su
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-10       Impact factor: 2.629

Review 8.  A review of in vitro and in vivo studies on the efficacy of herbal medicines for primary dysmenorrhea.

Authors:  Kyoung-Sun Park; Kang-In Park; Deok-Sang Hwang; Jin-Moo Lee; Jun-Bock Jang; Chang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-05       Impact factor: 2.629

9.  EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.

Authors:  A B Abera; K J Sales; R D Catalano; A A Katz; H N Jabbour
Journal:  Cell Signal       Date:  2009-09-25       Impact factor: 4.315

10.  Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.

Authors:  Kurt J Sales; Vivien Grant; Henry N Jabbour
Journal:  Mol Cell Endocrinol       Date:  2008-02-03       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.